Chikungunya virus is an enveloped, positive-sense single-stranded RNA alphavirus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes. While mortality remains low, generally below 0.1 percent, the broader public health burden arises from severe polyarthralgia that can persist for months or even years in a substantial fraction of patients across tropical and subtropical regions. With no approved antiviral therapy or licensed vaccine currently available, diagnostic accuracy sits at the center of clinical management and transmission control. Yet existing diagnostic tools face significant practical constraints, particularly in point-of-care and field settings.

Serological methods such as enzyme-linked immunosorbent assay suffer from cross-reactivity with related alphaviruses, including Ross River and O’nyong-nyong viruses, reducing diagnostic specificity. Real-time reverse transcription polymerase chain reaction offers high sensitivity during the acute phase but depends on laboratory infrastructure, trained personnel, and controlled sample handling. Virus isolation in cell culture provides confirmatory results but requires biosafety level-3 facilities and extended processing time. These limitations have motivated the search for rapid, label-free sensing approaches capable of operating at clinically relevant concentrations in decentralized environments.

The new work turns to the terahertz band, spanning roughly 0.1 to 10 THz, which lies between microwave and infrared regions of the electromagnetic spectrum. Terahertz radiation is non-ionising, with photon energies in the millielectronvolt range, allowing interaction with biological samples without causing ionising damage. Crucially, terahertz waves couple to low-frequency vibrational and rotational modes of biomolecules such as proteins, nucleic acids, and polysaccharides, producing measurable spectral features that support label-free detection. Because biological media including blood plasma and viral suspensions exhibit refractive-index variations in this domain, differences on the order of 0.01 to 0.02 refractive-index units can shift resonance frequency and field distribution when coupled to resonant sensing structures.

The proposed sensor is built around a periodically repeated square unit cell containing two identical square resonators, 2000 nanometers on a side, coated with tungsten disulfide—a two-dimensional transition metal dichalcogenide with strong light–matter interaction, high carrier mobility, and excellent dielectric confinement. This layer localizes the electric field in the sensing region and increases the interaction volume between the resonant field and the surrounding analyte. A pair of concentric circular rings, 3200 and 3800 nanometers in diameter and functionalized with MXene, surrounds the resonators, enhancing electromagnetic coupling, promoting efficient charge transport, and strengthening plasmonic interactions between resonator elements. An outer gold ring, 6000 nanometers in diameter, serves as the main plasmonic resonator supporting strong localized surface plasmon resonances with low optical loss. The entire multi-resonant assembly is embedded within a monolayer graphene sheet measuring 14,000 by 14,000 nanometers, which acts as a broadband absorber and a high-mobility charge transport medium whose electrically tunable chemical potential allows dynamic, active control of the resonance characteristics. Copper elements woven into the architecture provide supplementary conductive pathways that reinforce current distribution and coupling among the hybrid resonators. The structure rests on a silicon dioxide substrate, chosen for its low dielectric loss and mechanical robustness, which preserves the resonance quality factor.

The authors stress that the multilayer design is compatible with established microfabrication techniques. Fabrication would begin with a cleaned silicon dioxide substrate, followed by polymer-assisted transfer of monolayer graphene and thermal annealing. Gold and copper resonators can be deposited through electron-beam evaporation or magnetron sputtering with lift-off patterning, MXene rings through solution-based deposition, and the tungsten disulfide layer through chemical vapor deposition or thin-film transfer. With a unit-cell dimension of approximately 14 micrometers, the required feature sizes fall comfortably within conventional photolithography capabilities, and because fabrication imperfections remain far smaller than the operating terahertz wavelength, moderate tolerances are expected to have only limited influence on the electromagnetic response. For biosensing, the graphene surface could subsequently be functionalized with chikungunya-specific antibodies or aptamers using EDC/NHS or pyrene-based linker chemistries.

The electromagnetic modeling, performed in COMSOL Multiphysics, reveals a pronounced resonance at 0.355 THz, where electric-field simulations show the strongest and most spatially extensive enhancement. Varying the graphene chemical potential from 0.1 to 0.9 electronvolts produced dramatic modulation of the transmission contrast, which increased roughly 36-fold at the highest bias, from less than one percentage point to more than 27 percentage points, while peak transmission remained essentially unchanged above 98.6 percent. This asymmetric response—stable maxima paired with strongly modulated minima—arises because increasing chemical potential enhances graphene’s intraband conductivity, deepening resonant absorption through stronger light–matter interaction. The sensor also demonstrated remarkable angular robustness, maintaining peak transmittance above 97.8 percent across incident angles from 0 to 80 degrees, an important tolerance for realistic deployment where normal incidence cannot always be guaranteed.

Geometric optimization identified an outer circular resonator radius of 2500 nanometers and a square resonator side length of 2500 nanometers as the dimensions that maximize resonance strength, driving minimum transmittance down to approximately 65 to 67 percent and signifying optimal electromagnetic confinement within the active sensing region. When evaluated across refractive indices from 1.33 to 1.39, a range encompassing reported values for healthy plasma (approximately 1.35 RIU), healthy platelets (1.39 RIU), chikungunya-infected plasma (1.33 RIU), and infected platelets (1.38 RIU), the optimized configuration achieved a maximum sensitivity of 907 GHz/RIU, a figure of merit of 18.519 RIU⁻¹, a minimum detection limit of 0.061 RIU, a sensor resolution of 55.178, and a refractive-index resolution of 0.001 RIU. In comparative benchmarks against recently reported graphene- and hybrid-material-based terahertz biosensors—including graphene/copper/aluminum, graphene/silicon dioxide, MXene–graphene–black phosphorus, and graphene-integrated copper–silver designs—the proposed architecture’s sensitivity exceeded most published values, reflecting the synergistic field confinement produced by the five-material stack.

The machine-learning component addresses one of the central bottlenecks in metasurface development: the computational cost of repeated full-wave finite-element simulations during structural optimization. The team trained an XGBoost regressor, an ensemble method based on gradient-boosted decision trees, on simulation data covering incidence-angle variation and circular-ring dimension variation, using stratified sampling with 80 percent of data for training and 20 percent held out for independent testing, alongside five-fold cross-validation and grid-search hyperparameter optimization. The model captured more than 99.7 percent of response variance on unseen data, with mean absolute percentage errors below 0.162 percent and prediction accuracies from 99.838 to 99.959 percent. Acting as a computational surrogate, the trained model enables rapid interpolation across the design space without sacrificing the fidelity of the underlying electromagnetic model.

The authors are careful to frame the work as a computational proof-of-concept rather than an experimentally validated diagnostic. The sensor detects changes in the local dielectric environment surrounding the resonators, not viral particles or nucleic acids directly, and refractive-index sensing alone cannot intrinsically distinguish chikungunya from other viruses with similar dielectric properties. Analytical specificity in practice will depend on surface biofunctionalization with chikungunya-specific recognition molecules immobilized on the graphene or gold sensing surface. Future work will focus on device fabrication, biofunctionalization, calibration with reference refractive-index standards, experimental validation with clinically relevant plasma and platelet samples, and systematic evaluation of selectivity against related arboviruses—steps that would transform this numerically validated platform into a practical tool for rapid, label-free infectious disease diagnostics in the field.

Fundamentally, the principle behind this biosensing method lies in the "coffee-ring effect," a commonplace occurrence familiar to anyone who has ever spilled a drop of coffee that later dries into an unmistakable ring-shaped residue. This physical effect results from fluid flow dynamics where suspended particles are transported and deposited unevenly during evaporation. The research team capitalizes on this tendency by engineering plasmonic nanoparticles to concentrate selectively along the drying droplet’s periphery, thus amplifying local electromagnetic fields and significantly enhancing signal detection capabilities.

Plasmonics, the science of harnessing electron oscillations at metallic nanostructure surfaces, plays a pivotal role here. When light interacts with these nanostructures, it induces collective electron oscillations, or surface plasmons, which generate intense localized electromagnetic fields. These enhanced fields dramatically improve the sensitivity of a myriad of optical sensing techniques — such as surface-enhanced Raman scattering (SERS) — enabling the detection of biomolecules present at ultra-low concentrations.

The researchers strategically dispersed plasmonic nanoparticles within the analyte-laden fluid droplet. Upon drying on hydrophilic substrates, the particles spontaneously self-assembled along the droplet’s boundary, forming highly uniform, reproducible plasmonic rings. These rings act as hot spots, significantly boosting optical signals from biological markers attached to the nanoparticle surfaces. The result is a robust biosensing interface capable of revealing subtle biochemical alterations indicative of various pathologies.

Crucially, to interpret the complex optical signals generated by the plasmonic coffee-ring structures, the team employed sophisticated AI algorithms. By integrating machine learning models with biosensor outputs, they achieved real-time classification and quantification of biomarkers, overcoming inherent variations in sample composition, environmental noise, and instrumental factors. This AI-assisted interpretation lends the system unparalleled accuracy and robustness, vital for reliable point-of-care applications.

This research delineates a seamless workflow wherein patient samples—such as blood, saliva, or urine—require only a minute volume for testing. Upon depositing the sample onto the sensor platform and allowing the droplet to dry, operators need only to perform optical interrogation via compact portable devices. Subsequently, embedded AI models decipher the biosensing signals, outputting diagnostic results within minutes, a remarkable improvement over conventional multi-step laboratory assays prone to delays.

The implications of this platform extend beyond mere speed and sensitivity. The fabrication process for the sensor substrates is inexpensive and scalable, relying on readily available materials and straightforward chemical synthesis routes for the plasmonic nanoparticles. This cost-effective design underscores the potential for widespread deployment in resource-limited settings, remote areas, or emergency scenarios where rapid, decentralized diagnostic capability is critically needed.

Delving into the technical specifics of materials, the team employed gold and silver nanoparticles with tailored morphologies tuned to optimize plasmonic resonances in the visible spectrum. Rigorous characterization using electron microscopy, spectroscopy, and computational electromagnetic simulations ensured the reproducibility and efficiency of nanoparticle assembly within the coffee-ring patterns. This meticulous nanoparticle engineering is vital for achieving uniform signal enhancement across batches.

Furthermore, the study addresses challenges frequently encountered with biosensors, such as nonspecific binding and signal variability. By functionalizing the nanoparticle surfaces with selective bioreceptors—such as antibodies or aptamers—they ensured targeted analyte capture with minimal background interference. The AI algorithms were further trained to filter out residual noise and distinguish genuine biomarker signals, enhancing diagnostic confidence.

One of the most compelling aspects of this work is its adaptable nature. Although the current demonstration focuses on detecting protein biomarkers linked to infectious diseases and cancer, the underlying platform is adaptable to a broad spectrum of biological targets. Modifying surface chemistries can customize the biosensor for nucleic acids, metabolites, or environmental toxins, heralding a new class of versatile, multiplexed diagnostic tools.

The integration of AI transforms conventional biosensing into a smart diagnostic system. The authors engineered the software pipeline to learn continuously from accumulated data, improving predictive accuracy as more samples are processed. This adaptive learning framework embodies the concept of continual improvement, potentially enabling personalized diagnostic thresholds tuned to patient populations or even individual physiological variability.

Beyond diagnostics, this plasmonic coffee-ring platform offers exciting prospects for fundamental biomedical research. Its high sensitivity and spatial resolution might enable detecting transient molecular interactions or monitoring dynamic cellular responses in real time. This would pave the way for novel investigative methodologies, spanning from drug discovery to systems biology studies.

Importantly, the researchers conducted extensive validation studies benchmarking their device against gold-standard clinical assays. The results demonstrated impressive concordance, indicating that this point-of-care sensor could reliably approximate laboratory-based diagnostics. This level of validation is paramount to fostering clinician trust and facilitating eventual clinical adoption.

The study also explored the user-interface considerations essential for practical deployment. By combining the sensor with smartphone-based optical readers and intuitive applications, the system empowers non-specialist users to perform diagnostics with minimal training. This democratization of testing aligns with global health priorities emphasizing accessibility and patient autonomy.

Looking ahead, the team envisions leveraging advances in nanophotonics, microfluidics, and expanded AI capabilities to further miniaturize and automate the platform. Incorporating multiplexed detection channels could transform a single assay into a comprehensive health monitoring panel. Moreover, coupling biosensing with wireless data transmission enables integration into telemedicine networks, amplifying its societal impact.

In summary, this pioneering work on plasmonic coffee-ring biosensing combined with AI-driven analysis epitomizes the convergence of physics, nanotechnology, and data science to provide scalable, rapid, and accurate diagnostics. By transforming a deceptively simple natural phenomenon into a sophisticated biosensing tool, this technology heralds a new era of point-of-care healthcare innovation poised to improve outcomes worldwide.

Subject of Research: Development of a plasmonic coffee-ring biosensing platform integrated with AI for enhanced point-of-care diagnostics.

Article Title: Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics.

Article References:
Behrouzi, K., Khodabakhshi Fard, Z., Chen, CM. et al. Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics. Nat Commun 16, 4597 (2025). https://doi.org/10.1038/s41467-025-59868-y

Image Credits: AI Generated